Key statistics
On Wednesday, Emergent BioSolutions Inc (ER4:BRN) closed at 8.14, -38.78% below its 52-week high of 13.29, set on Jul 30, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 8.14 |
---|---|
High | 8.14 |
Low | 8.14 |
Bid | 8.32 |
Offer | 8.37 |
Previous close | 8.14 |
Average volume | -- |
---|---|
Shares outstanding | 54.02m |
Free float | 52.87m |
P/E (TTM) | -- |
Market cap | 353.83m USD |
EPS (TTM) | -11.24 USD |
Data delayed at least 15 minutes, as of Aug 21 2024.
More ▼
Announcements
- Emergent BioSolutions Announces Agreement to Settle Securities Class Action Litigation
- Emergent BioSolutions Awarded Research and Development Option valued at $41.9 Million for continued Advanced Development and Procurement of Ebanga™ Treatment for Ebola
- Emergent BioSolutions Successfully Refinances Debt & Further Strengthens Financial Profile
- Emergent BioSolutions Expands Ready to Rescue Initiative to Support Widespread Opioid Emergency Preparedness
- Emergent BioSolutions’ ACAM2000®, (Smallpox and Mpox (Vaccinia) Vaccine, Live) Receives U.S. FDA Approval for Mpox Indication; Public Health Mpox Outbreak Continues Across Africa & Other Regions
- Emergent BioSolutions Finalizes Sale of Baltimore-Camden Manufacturing Site to Bora Pharmaceuticals
- Emergent BioSolutions Responds to Mpox Public Health Emergency as Cases Surge in Africa
- Emergent BioSolutions Reports Second Quarter 2024 Financial Results
- Emergent BioSolutions Expands NARCAN® Nasal Spray Distribution Capabilities to Enhance Customer Delivery Experience Across the Country
- Emergent BioSolutions Completes Sale of RSDL® (Reactive Skin Decontamination Lotion) Kit to SERB Pharmaceuticals for $75 Million
More ▼